Report Id: PAPIM0320
Active Pharmaceutical Ingredient/ API Market Size By Type of Synthesis (Biotech Active Pharmaceutical Ingredients , Biotech Active Pharmaceutical Ingredients, Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), By Therapeutic Application (Diabetes, Respiratory Diseases, Communicable Diseases, Oncology, Pain Management, Cardiovascular Diseases, Other Therapeutic Applications), By Type of Drug (Active Pharmaceutical Ingredient Market, By Potency, Over-The-Counter Drugs, Prescription Drugs), By Type of Manufacturer (Merchant API Manufacturers, Captive API Manufacturers), By Type (Generic Active Pharmaceutical Ingredients, Innovative Active Pharmaceutical Ingredients), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
API is synthetically and organically dynamic parts of medicines with direct impact in cure, moderation, treatment and counteractive action of maladies.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Glaxosmithkline PLC
- Merck & Co. Inc.
- Abbvie Inc.
- F. Hoffmann-La Roche
- Astrazeneca
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
4
REPORT DESCRIPTION
Active pharmaceutical ingredients are an active ingredient of any drug or tablet, which holds medicinal properties. Some drugs that joint therapy have many active ingredients to indulgence different disorders. Active Pharmaceutical Ingredient are servings of any drugs, which are biologically active in nature. The APIs have important use in the manufacturing of effective and safe medicines. Depending on the drug’s managed dosage, the reactions and results differ according to the condition and use for specific treatment of diseases. The active pharmaceutical ingredients market is patent by cutthroat competition and it is challenging but not impossible for any new entrants seeking to arrive this lucrative market. Potential stakeholders are highly directed to raise to the opposition landscape chapter of the active pharmaceutical ingredients market report. Now, PMR has summarized several prominent organizations active in the global active pharmaceutical ingredients market.
The Global Active Pharmaceutical Ingredient (API) Market is segmented on the lines of its manufacturing process, API type, therapeutic area, drug type and regional. supported manufacturing process segmentation it covers captive, contract. supported API type segmentation it covers synthetic chemical API, biological API. supported therapeutic area segmentation it covers cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, other therapeutics uses. supported drug type segmentation it covers branded prescribed drugs, generic prescribed drugs, OTC prescribed drugs.
The global Active Pharmaceutical Ingredient/ API market is segregated on the basis of Type of Synthesis as Biotech Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients, Synthetic Active Pharmaceutical Ingredients, and Biotech Active Pharmaceutical Ingredients. Based on Therapeutic Application the global Active Pharmaceutical Ingredient/ API market is segmented in Diabetes, Respiratory Diseases, Communicable Diseases, Oncology, Pain Management, Cardiovascular Diseases, and Other Therapeutic Applications. Based on Type of Drug the global Active Pharmaceutical Ingredient/ API market is segmented in Active Pharmaceutical Ingredient Market, By Potency, Over-The-Counter Drugs, and Prescription Drugs.
Based on Type of Manufacturer, the global Active Pharmaceutical Ingredient/ API market is segmented in Merchant API Manufacturers and Captive API Manufacturers. The report also bifurcates the global Active Pharmaceutical Ingredient/ API market based on Type in Generic Active Pharmaceutical Ingredients and Innovative Active Pharmaceutical Ingredients.
The global Active Pharmaceutical Ingredient/ API market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Active Pharmaceutical Ingredient/ API market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Glaxosmithkline PLC, Merck & Co., Inc., Abbvie Inc., F. Hoffmann-La Roche, Astrazeneca, Pfizer, Inc., Novartis AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, and others are among the major players in the global Active Pharmaceutical Ingredient/ API market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Active Pharmaceutical Ingredient/ API Market has been segmented as below:
Active Pharmaceutical Ingredient/ API Market, By Type of Synthesis
- Biotech Active Pharmaceutical Ingredients
- Biotech Active Pharmaceutical Ingredients
- Synthetic Active Pharmaceutical Ingredients
- Biotech Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredient/ API Market, By Therapeutic Application
- Diabetes
- Respiratory Diseases
- Communicable Diseases
- Oncology
- Pain Management
- Cardiovascular Diseases
- Other Therapeutic Applications
Active Pharmaceutical Ingredient/ API Market, By Type of Drug
- Active Pharmaceutical Ingredient Market, By Potency
- Over-The-Counter Drugs
- Prescription Drugs
Active Pharmaceutical Ingredient/ API Market, By Type of Manufacturer
- Merchant API Manufacturers
- Captive API Manufacturers
Active Pharmaceutical Ingredient/ API Market, By Type
- Generic Active Pharmaceutical Ingredients
- Innovative Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredient/ API Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Active Pharmaceutical Ingredient/ API Market, By Company
- Glaxosmithkline PLC
- Merck & Co., Inc.
- Abbvie Inc.
- F. Hoffmann-La Roche
- Astrazeneca
- Pfizer, Inc.
- Novartis AG
- Sanofi
- Boehringer Ingelheim
- Bristol-Myers Squibb\
- Teva Pharmaceutical Industries Ltd.
- ELI Lilly and Company
The report covers:
- Global Active Pharmaceutical Ingredient/ API market sizes from 2022 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global Active Pharmaceutical Ingredient/ API market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Active Pharmaceutical Ingredient/ API market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global Active Pharmaceutical Ingredient/ API market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Active Pharmaceutical Ingredient/ API market share. Major industry players with significant revenue share include Glaxosmithkline PLC, Merck & Co., Inc., Abbvie Inc., F. Hoffmann-La Roche, Astrazeneca, Pfizer, Inc., Novartis AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, and others.
Reasons to Buy this Report:
- Gain detailed insights on the Active Pharmaceutical Ingredient/ API industry trends
- Find complete analysis on the market status
- Identify the Active Pharmaceutical Ingredient/ API market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Some of the recent developments in Active Pharmaceutical Ingredient/ API Market are as follows:
Pfizer, Inc.
- 07-2020: Pfizer declared that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program being developed to support protect against SARS-CoV-2, received Fast Track designation from the U.S. Food and Drug Administration.
- 06-2020: Pfizer Inc has declared the launch of the Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance, a new multi-year, public-private research collaboration with the governments of Ghana, Kenya, Malawi and Uganda to track resistance patterns and better understand the burden of antimicrobial resistance on patients living in low- and middle-income countries.
Abbvie Inc.
- 07-2020: AbbVie company declared that the U.S. Food and Drug Administration approved a supplemental Biologics License Application that supports expanded use of BOTOX® for the treatment of spasticity in pediatric patients 2 years of age and older, including those with lower limb spasticity caused by cerebral palsy.
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
haemophilia A therapeutics market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. Active Pharmaceutical Ingredient/ API Market, By Type of Synthesis
5.1 Introduction
5.2 Biotech Active Pharmaceutical Ingredients
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Biotech Active Pharmaceutical Ingredients
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Synthetic Active Pharmaceutical Ingredients
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Biotech Active Pharmaceutical Ingredients
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Active Pharmaceutical Ingredient/ API Market, By Therapeutic Application
6.1 Introduction
6.2 Diabetes
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Respiratory Diseases
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Communicable Diseases
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Oncology
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Pain Management
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Cardiovascular Diseases
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Other Therapeutic Applications
6.8.1 Market Overview
6.8.2 Market Size and Forecast
7. Active Pharmaceutical Ingredient/ API Market, By Type of Drug
7.1 Introduction
7.2 Active Pharmaceutical Ingredient Market, By Potency
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Over-The-Counter Drugs
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Prescription Drugs
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8. Active Pharmaceutical Ingredient/ API Market, By Type of Manufacturer
8.1 Introduction
8.2 Merchant API Manufacturers
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Captive API Manufacturers
8.3.1 Market Overview
8.3.2 Market Size and Forecast
9. Active Pharmaceutical Ingredient/ API Market, By Type
9.1 Introduction
9.2 Generic Active Pharmaceutical Ingredients
9.2.1 Market Overview
9.2.2 Market Size and Forecast
9.3 Innovative Active Pharmaceutical Ingredients
9.3.1 Market Overview
9.3.2 Market Size and Forecast
10. Active Pharmaceutical Ingredient/ API Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 North America Active Pharmaceutical Ingredient/ API, By Type of Synthesis
10.2.2 North America Active Pharmaceutical Ingredient/ API, By Therapeutic Application
10.2.3 North America Active Pharmaceutical Ingredient/ API, By Type of Drug
10.2.4 North America Active Pharmaceutical Ingredient/ API, By Type of Manufacturer
10.2.5 North America Active Pharmaceutical Ingredient/ API, By Type
10.3 Europe
10.3.1 Europe Active Pharmaceutical Ingredient/ API, By Type of Synthesis
10.3.2 Europe Active Pharmaceutical Ingredient/ API, By Therapeutic Application
10.3.3 Europe Active Pharmaceutical Ingredient/ API, By Type of Drug
10.3.4 Europe Active Pharmaceutical Ingredient/ API, By Type of Manufacturer
10.3.5 Europe Active Pharmaceutical Ingredient/ API, By Type
10.4 Asia-Pacific
10.4.1 Asia-Pacific Active Pharmaceutical Ingredient/ API, By Type of Synthesis
10.4.2 Asia-Pacific Active Pharmaceutical Ingredient/ API, By Therapeutic Application
10.4.3 Asia-Pacific Active Pharmaceutical Ingredient/ API, By Type of Drug
10.4.4 Asia-Pacific Active Pharmaceutical Ingredient/ API, By Type of Manufacturer
10.4.5 Asia-Pacific Active Pharmaceutical Ingredient/ API, By Type
10.5 Rest of the World
10.5.1 Rest of the World Active Pharmaceutical Ingredient/ API, By Type of Synthesis
10.5.2 Rest of the World Active Pharmaceutical Ingredient/ API, By Therapeutic Application
10.5.3 Rest of the World Active Pharmaceutical Ingredient/ API, By Type of Drug
10.5.4 Rest of the World Active Pharmaceutical Ingredient/ API, By Type of Manufacturer
10.5.5 Rest of the World Active Pharmaceutical Ingredient/ API, By Type
11. Competitive Insights
11.1 Key Insights
11.2 Company Market Share Analysis
11.3 Strategic Outlook
11.3.1 Mergers & Acquisitions
11.3.2 New Product Development
11.3.3 Portfolio/Production Capacity Expansions
11.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
11.3.5 Others
12. Company Profiles
12.1 Glaxosmithkline PLC
12.1.1 Company Overview
12.1.2 Product/Service Landscape
12.1.3 Financial Overview
12.1.4 Recent Developments
12.2 Merck & Co., Inc.
12.2.1 Company Overview
12.2.2 Product/Service Landscape
12.2.3 Financial Overview
12.2.4 Recent Developments
12.3 Abbvie Inc.
12.3.1 Company Overview
12.3.2 Product/Service Landscape
12.3.3 Financial Overview
12.3.4 Recent Developments
12.4 F. Hoffmann-La Roche
12.4.1 Company Overview
12.4.2 Product/Service Landscape
12.4.3 Financial Overview
12.4.4 Recent Developments
12.5 Astrazeneca
12.5.1 Company Overview
12.5.2 Product/Service Landscape
12.5.3 Financial Overview
12.5.4 Recent Developments
12.6 Pfizer, Inc.
12.6.1 Company Overview
12.6.2 Product/Service Landscape
12.6.3 Financial Overview
12.6.4 Recent Developments
12.7 Novartis AG
12.7.1 Company Overview
12.7.2 Product/Service Landscape
12.7.3 Financial Overview
12.7.4 Recent Developments
12.8 Sanofi
12.8.1 Company Overview
12.8.2 Product/Service Landscape
12.8.3 Financial Overview
12.8.4 Recent Developments
12.9 Boehringer Ingelheim
12.9.1 Company Overview
12.9.2 Product/Service Landscape
12.9.3 Financial Overview
12.9.4 Recent Developments
12.10 Bristol-Myers Squibb
12.10.1 Company Overview
12.10.2 Product/Service Landscape
12.10.3 Financial Overview
12.10.4 Recent Developments
12.11 Teva Pharmaceutical Industries Ltd.
12.11.1 Company Overview
12.11.2 Product/Service Landscape
12.11.3 Financial Overview
12.11.4 Recent Developments
12.12 ELI Lilly and Company
12.12.1 Company Overview
12.12.2 Product/Service Landscape
12.12.3 Financial Overview
12.12.4 Recent Developments
The Active Pharmaceutical Ingredient/ API Market has been segmented as below:
Active Pharmaceutical Ingredient/ API Market, By Type of Synthesis
- Biotech Active Pharmaceutical Ingredients
- Biotech Active Pharmaceutical Ingredients
- Synthetic Active Pharmaceutical Ingredients
- Biotech Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredient/ API Market, By Therapeutic Application
- Diabetes
- Respiratory Diseases
- Communicable Diseases
- Oncology
- Pain Management
- Cardiovascular Diseases
- Other Therapeutic Applications
Active Pharmaceutical Ingredient/ API Market, By Type of Drug
- Active Pharmaceutical Ingredient Market, By Potency
- Over-The-Counter Drugs
- Prescription Drugs
Active Pharmaceutical Ingredient/ API Market, By Type of Manufacturer
- Merchant API Manufacturers
- Captive API Manufacturers
Active Pharmaceutical Ingredient/ API Market, By Type
- Generic Active Pharmaceutical Ingredients
- Innovative Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredient/ API Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Active Pharmaceutical Ingredient/ API Market, By Company
- Glaxosmithkline PLC
- Merck & Co., Inc.
- Abbvie Inc.
- F. Hoffmann-La Roche
- Astrazeneca
- Pfizer, Inc.
- Novartis AG
- Sanofi
- Boehringer Ingelheim
- Bristol-Myers Squibb\
- Teva Pharmaceutical Industries Ltd.
- ELI Lilly and Company
Got a question? We've got answers. If you have some other questions, see our support center.
What is the segment’s covered for the Active Pharmaceutical Ingredient (API) Market?
The segment included in the Active Pharmaceutical Ingredient (API) Market is Type of Synthesis, Therapeutic Application, Type of Drug, Type of Manufacturer, Type, Company and region.
Who are the major key vendors in the Active Pharmaceutical Ingredient (API) Market?
Some key players operating in the Active Pharmaceutical Ingredient (API) Market include Glaxosmithkline PLC, Merck & Co., Inc., Abbvie Inc., F. Hoffmann-La Roche, Astrazeneca, Pfizer, Inc., Novartis AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE